FDA alerts providers to COVID-19 rapid test recall
The Food and Drug Administration last week announced a Class 1 recall of two COVID-19 tests the agency had not authorized or approved. Due to the potential for false results, FDA said health care providers and testing programs should consider retesting patients with an authorized test if they administered the CovClear COVID-19 Rapid Antigen Test less than two weeks ago and suspect an inaccurate result, or administered the ImmunoPass COVID-19 Neutralizing Antibody Rapid Test and suspect a recent or prior COVID-19 infection.
Related News Articles
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…